Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event
ConclusionsOur analysis of a well-characterised DILI cohort further supports the potential of metamizole causing DILI and provides important features for the establishment of a signature pattern of liver injury observed in patients treated with metamizole.Clinical Trial RegistrationClinicalTrials.gov: NCT 02353455.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research
More News: Bilirubin | Biochemistry | Clinical Trials | Drugs & Pharmacology | Jaundice | Liver | Study | Urology & Nephrology